Identifying Blood-Based Markers for Optimized Bipolar Androgen Therapy in mCRPC

madman

Super Moderator
1718516599705.webp



Samuel Denmeade, MD, of Johns Hopkins University School of Medicine, highlights his research on blood-based markers of differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial.

This research was presented as a late-breaking abstract at the 2024 American Society of Clinical Oncology Annual Meeting.
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

Beyond Testosterone Podcast

Online statistics

Members online
14
Guests online
448
Total visitors
462

Latest posts

Back
Top